RSG
57
-7
HOG
43
3
FIS
51
-2
TEL
63
2
PG
53
-2
EQR
57
-2
TJX
48
-6
ZION
52
2
CB
58
-2
T
60
-3
MA
69
2
CL
59
-2
TRIP
57
5
HST
52
3
SYK
59
-5
O
37
-3
TGT
48
-2
EW
16
-9
CTSH
57
-5
FDX
51
4
RSG
57
-7
HOG
43
3
FIS
51
-2
TEL
63
2
PG
53
-2
EQR
57
-2
TJX
48
-6
ZION
52
2
CB
58
-2
T
60
-3
MA
69
2
CL
59
-2
TRIP
57
5
HST
52
3
SYK
59
-5
O
37
-3
TGT
48
-2
EW
16
-9
CTSH
57
-5
FDX
51
4
Financhill
Back

VYNE Therapeutics Stock Price Chart

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22

VYNE
VYNE Therapeutics

Last Price:
1.89
Seasonality Move:
-14.98%

7 Day Trial

ALL ACCESS PASS

$ 7

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options
  • The current trend is relatively stagnant and VYNE is experiencing selling pressure, which indicates risk of future bearish movement.

VYNE Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.84 Sell
20-day SMA: 1.84 Sell
50-day SMA: 1.9 Sell
200-day SMA: 2.26 Sell
8-day EMA: 1.84 Sell
20-day EMA: 1.84 Sell
50-day EMA: 1.91 Sell
200-day EMA: 2.47 Sell

VYNE Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 48.2 Sell
Chaikin Money Flow: -10809 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 1.89) Sell
Bollinger Bands (100): (1.77 - 2.49) Sell

VYNE Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for VYNE Therapeutics Stock

Is VYNE Therapeutics Stock a Buy?

  • VYNE Therapeutics share price is 1.83 while VYNE 8-day simple moving average is 1.84, which is a Sell signal.
  • The stock price of VYNE is 1.83 while VYNE Therapeutics 20-day SMA is 1.84, which makes it a Sell.
  • VYNE Therapeutics 50-day simple moving average is 1.90 while VYNE share price is 1.83, making it a Sell technically.
  • VYNE stock price is 1.83 and VYNE Therapeutics 200-day simple moving average is 2.26, creating a Sell signal.

VYNE Technical Analysis vs Fundamental Analysis

Sell
22
VYNE Therapeutics (VYNE) is a Sell

Is VYNE Therapeutics a Buy or a Sell?

  • VYNE Therapeutics stock is rated a Sell
    The current VYNE Therapeutics [VYNE] share price is $1.83. The Score for VYNE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.

VYNE Therapeutics Stock Info

Market Cap:
26.99M
Price in USD:
1.83
Share Volume:
10.81K

VYNE Therapeutics 52-Week Range

52-Week High:
4.48
52-Week Low:
1.57
Sell
22
VYNE Therapeutics (VYNE) is a Sell

VYNE Therapeutics Share Price Forecast

Is VYNE Therapeutics Stock a Buy?

  • VYNE Therapeutics share price is 1.83 while VYNE 8-day exponential moving average is 1.84, which is a Sell signal.
  • The stock price of VYNE is 1.83 while VYNE Therapeutics 20-day EMA is 1.84, which makes it a Sell.
  • VYNE Therapeutics 50-day exponential moving average is 1.91 while VYNE share price is 1.83, making it a Sell technically.
  • VYNE stock price is 1.83 and VYNE Therapeutics 200-day simple moving average is 2.47, creating a Sell signal.

Fundamental Analysis of VYNE Therapeutics

Is VYNE Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $1.05 per share.

Technical Analysis of VYNE Therapeutics

Should I short VYNE Therapeutics stock?

* VYNE Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.